17:02 EDT Gain Therapeutics (GANX) files $100M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GANX:
- Buy Rating for Gain Therapeutics: Promising Phase 1b Trial and Strong Financial Position Support Positive Outlook
- Buy Rating for Gain Therapeutics Driven by Promising Parkinson’s Program and Strong Financial Position
- Gain Therapeutics Reports Q1 2025 Financial Results
- Gain Therapeutics reports Q1 EPS (16c), consensus (18c)
- Gain Therapeutics reports preclinical data n GT-02287